Trial Profile
Phase II US trial of MRX 6 in atopic dermatitis
Status:
Not yet recruiting
Phase of Trial:
Phase II
Latest Information Update: 14 Jan 2015
Price :
$35
*
At a glance
- Drugs MRX 6 (Primary)
- Indications Atopic dermatitis
- Focus Therapeutic Use
- 12 Jan 2015 Status changed from planning to not yet recruiting, as reported in a Celsus Therapeutics media release.
- 12 Jan 2015 Results are expected in the first quarter of 2016, according to a Celsus Therapeutics media release.
- 12 Jan 2015 US FDA allows the IND for MRX 6 in atopic dermatitis, according to a Celsus Therapeutics media release.